MARKET

NBIO

NBIO

Nascent Biotech
EXMKT
0.0003
NaN%
Closed 09:30 02/20 EST
OPEN
--
PREV CLOSE
0.0003
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.084
52 WEEK LOW
0.0001
MARKET CAP
51.67K
P/E (TTM)
-0.0250
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NBIO last week (0209-0213)?
Weekly Report · 4d ago
Weekly Report: what happened at NBIO last week (0202-0206)?
Weekly Report · 02/09 09:49
Weekly Report: what happened at NBIO last week (0126-0130)?
Weekly Report · 02/02 09:48
Weekly Report: what happened at NBIO last week (0119-0123)?
Weekly Report · 01/26 09:48
Weekly Report: what happened at NBIO last week (0112-0116)?
Weekly Report · 01/19 09:52
Weekly Report: what happened at NBIO last week (0105-0109)?
Weekly Report · 01/12 09:51
Weekly Report: what happened at NBIO last week (1229-0102)?
Weekly Report · 01/05 09:48
Weekly Report: what happened at NBIO last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
More
About NBIO
Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company, which is engaged in developing monoclonal antibodies for the treatment of various types of cancer. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company's lead candidate, Pritumumab (PTB), is a human monoclonal antibody (Mab) that has progressed to Phase 2 clinical trials for the treatment of Brain Cancer. Pritumumab is a fully natural human IgG antibody that was derived using proprietary technology from a B-cell isolated from a tumor draining lymph node of a patient with cervical cancer. Its other products include CLNH5 and MultiPharm. MultiPharm is a proprietary platform technology that may have additive and synergistic effects not only for cancer therapy but also for diabetes, autoimmunity, and transplantation.

Webull offers Nascent Biotech Inc stock information, including EXMKT: NBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBIO stock methods without spending real money on the virtual paper trading platform.